生物反馈联合经皮电刺激阴部神经治疗低位前切除综合征:随机对照试验研究方案
低位前切除综合征影响约25-80%直肠癌术后患者,表现为排便失禁、便急和排便次数增多。本研究为两臂多中心随机对照试验,计划纳入242例直肠术后LARS患者,随机接受生物反馈联合经皮电刺激阴部神经(B-PEPNS)或单纯生物反馈,4周内各20次治疗,主要结局为LARS评分,次要结局为肛门直肠测压、盆底肌电图和EORTC QLQ-CR29评分,随访至6个月。
要点
- LARS影响约25-80%直肠癌术后患者,表现为排便失禁、便急和排便次数增多。
- 本试验比较B-PEPNS与单纯生物反馈,计划纳入242例,4周内各20次治疗。
- 主要结局为LARS评分,次要结局包括肛门直肠测压、盆底肌电图和EORTC QLQ-CR29评分。
核心结论
- 作者预期本研究将进一步提供B-PEPNS缓解LARS症状和改善直肠癌术后患者生活质量的证据。
研究设计与样本
- 两臂多中心随机对照试验,计划纳入242例直肠术后LARS患者,随机分为B-PEPNS干预组和生物反馈对照组。
- 两组均在4周内接受20次治疗,数据在基线、干预后1个月和随访6个月时收集。
主要发现
- 原文为研究方案,未报告试验结果。
关键数值与推荐
- 主要结局为LARS评分;次要结局为肛门直肠测压、盆底肌电图和EORTC QLQ-CR29评分。
- 干预组接受生物反馈联合经皮电刺激阴部神经(B-PEPNS),对照组接受生物反馈。
临床怎么用
- 原文为研究方案,未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Low anterior resection syndrome (LARS) is a distressing condition that affects approximately 25-80% of patients following surgery for rectal cancer. LARS is characterized by debilitating bowel dysfunction symptoms, including fecal incontinence, urgent bowel movements, and increased frequency of bowel movements. Although biofeedback therapy has demonstrated effectiveness in improving postoperative rectal control, the research results have not fulfilled expectations. Recent research has highlighted that stimulating the pudendal perineal nerves has a superior impact on enhancing pelvic floor muscle function than biofeedback alone. Hence, this study aims to evaluate the efficacy of a combined approach integrating biofeedback with percutaneous electrical pudendal nerve stimulation (B-PEPNS) in patients with LARS through a randomized controlled trial (RCT). METHODS AND ANALYSIS: In this two-armed multicenter RCT, 242 participants with LARS after rectal surgery will be randomly assigned to undergo B-PEPNS (intervention group) or biofeedback (control group). Over 4 weeks, each participant will undergo 20 treatment sessions. The primary outcome will be the LARS score. The secondary outcomes will be anorectal manometry and pelvic floor muscle electromyography findings and the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire-Colorectal 29 (EORTC QLQ-CR29) scores. Data will be collected at baseline, post-intervention (1 month), and follow-up (6 months). DISCUSSION: We anticipate that this study will contribute further evidence regarding the efficacy of B-PEPNS in alleviating LARS symptoms and enhancing the quality of life for patients following rectal cancer surgery. TRIAL REGISTRATION: Chinese Clincal Trials Register ChiCTR2300078101. Registered 28 November 2023.
引用
- Cao G, Zhang X, Wang F, et al. Biofeedback combined with percutaneous electrical pudendal nerve stimulation for the treatment of low anterior rectal resection syndrome: a study protocol for a randomized controlled trial. Trials. 2024. PMID: 38956630. doi:10.1186/s13063-024-08300-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。